Press release
Lung Cancer Surgery Market Size, and Growth Report | Expand at 4% CAGR by 2030
The global lung cancer surgery market is set to witness a growth rate of 4% in the next 5 years. Increasing incidence of lung cancer; advancements in surgical techniques, growing geriatric population; growing focus on early cancer detection and treatment; favorable reimbursement policies and integration of advanced imaging and diagnostic tools are some of the key factors driving the lung cancer surgery market.Lung cancer surgery is a medical procedure aimed at removing cancerous tissue from the lungs. It is primarily used to treat early-stage lung cancer, particularly non-small cell lung cancer (NSCLC), and involves various techniques such as lobectomy (removal of a lung lobe), pneumonectomy (removal of an entire lung), and segmentectomy (removal of part of a lobe). Advanced methods like video-assisted thoracoscopic surgery, and robotic-assisted thoracic surgery offer minimally invasive options, reducing recovery time and complications. Lung cancer surgery is often combined with other treatments, including chemotherapy, radiation, or immunotherapy, to improve patient outcomes and reduce recurrence.
Unlock key Insights! Fill out a quick inquiry to access a sample report: https://meditechinsights.com/lung-cancer-surgery-market/request-sample/
Increasing incidence of lung cancer to propel market demand
The increasing incidence of lung cancer indirectly drives the medical aesthetics market by fueling demand for aesthetic procedures to manage physical changes resulting from cancer treatments. According to the International Agency for Research (IARC), Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or 12.4% of all cancers globally. Lung cancer therapies, such as chemotherapy and radiation, often lead to hair loss, skin changes, and facial volume loss, prompting patients to seek cosmetic solutions for improved appearance and self-confidence. Additionally, advancements in minimally invasive aesthetic procedures, like dermal fillers and laser therapies, provide non-surgical options for cancer survivors. The growing focus on post-cancer care and the rising awareness of aesthetic treatments contribute to the expansion of the medical aesthetics market.
Advancements in surgical techniques are driving the market growth
Advancements in surgical techniques are significantly driving the lung cancer surgery market by improving precision, reducing complications, and enhancing patient outcomes. Minimally invasive procedures like video-assisted thoracoscopic surgery and robotic-assisted thoracic surgery enable smaller incisions, faster recovery times, and lower post-operative risks compared to traditional open surgeries. Enhanced imaging technologies, real-time navigation systems, and robotic platforms improve tumor localization and surgical accuracy, leading to better survival rates. Additionally, the adoption of personalized surgical approaches, based on genetic profiling and AI-driven decision-making, is further optimizing treatment, making surgery a preferred option for early-stage lung cancer patients.
Competitive Landscape Analysis
The global lung cancer surgery market is marked by the presence of established and emerging market players such as Intuitive Surgical, Medtronic, Johnson & Johnson, Olympus Corporation, Siemens Healthineers, Teleflex Incorporated, Accuray Incorporated, AngioDynamics, KARL STORZ SE & Co. KG, and Richard Wolf GmbH; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Get exclusive insights - download your sample report: https://meditechinsights.com/lung-cancer-surgery-market/
Global Lung Cancer Surgery Market Segmentation
This report by Medi-Tech Insights provides the size of the global lung cancer surgery market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, application, end user.
Market Size & Forecast (2023-2030), By Product, USD Million
Surgical Instruments
Powered Surgical Instruments
Hand Instruments
Monitoring and Visualizing Systems
Cameras and Video Support
Endoscopic Trocars with Optical Views
Endo surgical Equipment
Others
Market Size & Forecast (2023-2030), By Application, USD Million
Thoracotomy
Lobectomy
Sleeve Resection
Segmentectomy
Pneumonectomy
Minimally Invasive Surgeries
Market Size & Forecast (2023-2030), By End User, USD Million
Hospitals
Ambulatory Surgical Centers (ASCs)
Others
Top Related Reports
Lung Cancer Diagnostics Market: https://meditechinsights.com/global-lung-cancer-diagnostics-market/
Biopsy Devices Market Size & Trends Report: https://meditechinsights.com/global-biopsy-devices-market/
Cancer Diagnostics Market: https://meditechinsights.com/cancer-diagnostics-market/
Contact:
Ruta Halde
Associate, Medi-Tech Insights
Phone: +32 498 86 80 79
Email: info@meditechinsights.com
Website: https://meditechinsights.com/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Surgery Market Size, and Growth Report | Expand at 4% CAGR by 2030 here
News-ID: 3956011 • Views: …
More Releases from Medi-Tech Insights

Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR …
The global sterilization equipment market is set to experience significant growth, with an expected CAGR of 7-9% over the next 5 years. This growth is driven by increasing demand for sterilization in healthcare facilities, stringent infection control regulations, rising surgical procedures, necessity to curb hospital-acquired infections (HAIs), and advancements in sterilization technologies.
Sterilization equipment plays a critical role in ensuring the safety and hygiene of medical instruments, devices, and environments. These…

Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tec …
The global biologics market is set to witness a growth rate of 10-12% in the next 5 years. Rising prevalence of chronic diseases; continued advancements in biotechnology; growing investment in biopharmaceutical R&D; and growing strategic partnerships between biotech firms & larger pharmaceutical companies are some of the key factors driving the biologics market.
Biologics are a class of medications derived from living organisms, including proteins, sugars, and nucleic acids among others.…

Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements …
The global telemedicine market is set to witness a robust growth rate of 16-18% over the next five years. This growth is driven by the increasing adoption of digital healthcare solutions, a rise in chronic disease prevalence, an aging population demanding more accessible care, technological advancements in telehealth platforms, growing government support, and the shift toward remote patient monitoring and virtual care solutions.
Telemedicine refers to the remote diagnosis, treatment, and…

High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising …
The high flow oxygen therapy (HFOT) market is growing at a projected compound annual growth rate (CAGR) of around 7% in the forecast period. Key drivers include the rising prevalence of respiratory diseases such as COPD, pneumonia, and acute respiratory failure, along with increased adoption of non-invasive treatments. Technological advancements in HFOT devices and the growing elderly population further support market growth. However, high device costs and limited reimbursement in…
More Releases for Lung
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lung Cancer Drugs Industry Market Size Be by 2025?
The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate…
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lending And Payments Market?
The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787
This latest report researches the industry structure,…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…